Cas no 1210-52-2 (Dibenzothiophene,2,4,8-trimethyl-)

Dibenzothiophene, 2,4,8-trimethyl- is a sulfur-containing heterocyclic compound characterized by its fused aromatic ring structure with three methyl substituents at the 2, 4, and 8 positions. This derivative of dibenzothiophene exhibits enhanced thermal stability and solubility in organic solvents compared to its unsubstituted counterpart, making it suitable for applications in materials science and organic synthesis. Its rigid molecular framework and electron-rich sulfur center contribute to its utility in the development of optoelectronic materials, catalysts, and as a model compound in desulfurization studies. The compound's well-defined structure also facilitates precise modifications for tailored chemical and physical properties.
Dibenzothiophene,2,4,8-trimethyl- structure
1210-52-2 structure
Product Name:Dibenzothiophene,2,4,8-trimethyl-
CAS No:1210-52-2
MF:C15H14S
MW:226.336662769318
MDL:MFCD04972223
CID:117521
PubChem ID:50960
Update Time:2025-06-15

Dibenzothiophene,2,4,8-trimethyl- Chemical and Physical Properties

Names and Identifiers

    • Dibenzothiophene,2,4,8-trimethyl-
    • 2,4,8-TRIMETHYLDIBENZOTHIOPHENE
    • 2,3-DIMETHYL-4-CHLOROPYRIDINE-N-OXIDE
    • 2,4,8-Trimethyl-dibenzothiophen
    • 2,4,8-trimethyl-dibenzothiophene
    • 2,4,8-Trimethyldibenzothiophene100μg
    • Dibenzothiophene,2,4,8-trimethyl
    • Dibenzothiophene, 2,4,8-trimethyl
    • Dibenzothiophene, trimethyl-
    • 2,4,8-trimethyldibenzo[b,d]thiophene
    • DTXSID601036999
    • 1210-52-2
    • SCHEMBL14798100
    • FEQHEOIAYXXUHR-UHFFFAOYSA-N
    • 70021-48-6
    • MDL： MFCD04972223
    • Inchi： 1S/C15H14S/c1-9-4-5-14-12(7-9)13-8-10(2)6-11(3)15(13)16-14/h4-8H,1-3H3
    • InChI Key： FEQHEOIAYXXUHR-UHFFFAOYSA-N
    • SMILES： S1C2C=CC(C)=CC=2C2C=C(C)C=C(C)C1=2

Computed Properties

  • Exact Mass: 226.08200
  • Monoisotopic Mass: 226.082
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 0
  • Complexity: 262
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 28.2A^2
  • XLogP3: 5.4

Experimental Properties

  • PSA: 28.24000
  • LogP: 4.97970

Dibenzothiophene,2,4,8-trimethyl- Customs Data

  • HS CODE：2934999090
  • Customs Data：

    China Customs Code:

    2934999090

    Overview:

    2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Dibenzothiophene,2,4,8-trimethyl- Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
eNovation Chemicals LLC
K73853-5g
2,4,8-TRIMETHYLDIBENZOTHIOPHENE
 1210-52-2 95%
5g
 $2850 2025-02-19
eNovation Chemicals LLC
K73853-5g
2,4,8-TRIMETHYLDIBENZOTHIOPHENE
 1210-52-2 95%
5g
 $2850 2024-06-09
eNovation Chemicals LLC
K73853-5g
2,4,8-TRIMETHYLDIBENZOTHIOPHENE
 1210-52-2 95%
5g
 $2850 2025-03-03
eNovation Chemicals LLC
K73853-5g
2,4,8-TRIMETHYLDIBENZOTHIOPHENE
 1210-52-2 95%
5g
 $2850 2025-03-03

Dibenzothiophene,2,4,8-trimethyl- Related Literature

Additional information on Dibenzothiophene,2,4,8-trimethyl-

Recent Advances in the Study of Dibenzothiophene,2,4,8-trimethyl- (CAS: 1210-52-2) in Chemical Biology and Pharmaceutical Research

Dibenzothiophene derivatives, particularly 2,4,8-trimethyldibenzothiophene (CAS: 1210-52-2), have garnered significant attention in recent years due to their unique chemical properties and potential applications in pharmaceutical and chemical biology research. This compound, characterized by its sulfur-containing heterocyclic structure, has been explored for its role in drug development, material science, and environmental chemistry. The latest research highlights its promising biological activities, including anti-inflammatory, antimicrobial, and anticancer properties, making it a focal point for interdisciplinary studies.

Recent studies have focused on the synthesis and functionalization of 2,4,8-trimethyldibenzothiophene to enhance its bioavailability and therapeutic efficacy. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that modifications at the sulfur atom and methyl groups significantly improved the compound's interaction with biological targets, such as enzymes and receptors. These findings suggest that 2,4,8-trimethyldibenzothiophene could serve as a versatile scaffold for designing novel therapeutics, particularly in oncology and infectious diseases.

In addition to its pharmaceutical potential, 2,4,8-trimethyldibenzothiophene has been investigated for its environmental applications. Research published in Environmental Science & Technology (2024) revealed its efficacy in the degradation of persistent organic pollutants (POPs) due to its ability to act as a catalyst in advanced oxidation processes. This dual utility—both in medicine and environmental remediation—underscores the compound's versatility and broad applicability.

Despite these advancements, challenges remain in optimizing the synthesis of 2,4,8-trimethyldibenzothiophene to achieve higher yields and purity. A recent preprint on ChemRxiv (2024) proposed a novel catalytic method using transition metal complexes, which reduced byproduct formation and improved scalability. This methodological innovation could pave the way for large-scale production, facilitating further research and commercialization.

In conclusion, 2,4,8-trimethyldibenzothiophene (CAS: 1210-52-2) represents a promising compound with multifaceted applications in chemical biology and pharmaceuticals. Ongoing research aims to unravel its full potential, addressing synthesis challenges and expanding its therapeutic and environmental uses. Future studies are expected to explore its mechanisms of action in greater detail, potentially leading to breakthrough discoveries in drug development and sustainability.

1210-52-2 (Dibenzothiophene,2,4,8-trimethyl-) Related Products

Recommended suppliers
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.